EU secures potential COVID-19 drugs from Roche, Germany’s Merck – source
The deals cover Roche’s arthritis drug RoActemra and Merck’s multiple sclerosis drug Rebif - both seen as potential COVID-19…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Rebif
Merck Serono launches web-based software for people with MS
The software is available in six additional countries